Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Jocil

₹192.1 -1.5 | 0.8%

Market Cap ₹171 Cr.

Stock P/E 53.9

P/B 0.8

Current Price ₹192.1

Book Value ₹ 232.4

Face Value 10

52W High ₹263.5

Dividend Yield 1.3%

52W Low ₹ 162.7

Jocil Research see more...

Overview Inc. Year: 1978Industry: Chemicals

Jocil Ltd is a dynamic and innovative company that operates in the chemical and pharmaceutical industries. The company has established itself as a leading player in the market. Jocil specializes in the research, development, and manufacturing of high-quality chemical compounds and pharmaceutical products, catering to a diverse range of global clients. With a strong commitment to cutting-edge technology, ethical practices, and sustainable solutions, Jocil prides itself on delivering exceptional products and services. The company's dedicated team of experts continuously strives for excellence, ensuring that they stay at the forefront of the industry. Jocil's unwavering dedication to customer satisfaction and industry-leading practices has earned them a stellar reputation in their field.

Read More..

Jocil Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Peer Comparison

Jocil Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 197 172 216 284 242 193 200 180 218 172
Other Income 0 0 0 0 1 1 1 1 1 1
Total Income 198 173 216 285 243 193 201 181 220 173
Total Expenditure 193 169 213 279 238 189 195 178 216 175
Operating Profit 5 4 3 5 5 5 5 3 4 -2
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 2 2 2 2 2 2 2 1 1 2
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 3 2 1 3 3 3 4 2 2 -4
Provision for Tax 1 1 0 1 1 1 0 0 1 -1
Profit After Tax 2 2 1 2 2 2 3 1 2 -3
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 2 2 1 2 2 2 3 1 2 -3
Adjusted Earnings Per Share 2.7 1.9 0.8 2.6 2.6 2.5 3.5 1.5 2.1 -3.6

Jocil Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 408 375 331 393 376 341 402 446 565 754 919 770
Other Income 2 2 2 5 3 2 2 6 1 1 2 4
Total Income 409 377 333 398 379 344 404 452 567 755 922 775
Total Expenditure 372 349 305 361 360 331 396 427 545 738 902 764
Operating Profit 37 28 27 37 19 13 8 25 22 17 20 10
Interest 4 2 1 1 2 1 1 1 1 0 1 0
Depreciation 10 10 7 8 7 7 6 6 6 7 6 6
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 23 16 20 27 10 5 1 18 15 10 13 4
Provision for Tax 8 5 7 9 2 1 -2 5 2 2 3 0
Profit After Tax 15 11 13 18 8 4 3 12 14 7 10 3
Adjustments 0 0 0 0 1 3 1 -5 5 3 -5 0
Profit After Adjustments 15 11 13 18 10 7 4 8 18 10 5 3
Adjusted Earnings Per Share 16.5 12.8 14.8 20.4 9.2 4.6 3.6 14.1 15.3 8 11.3 3.5

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 22% 27% 22% 8%
Operating Profit CAGR 18% -7% 9% -6%
PAT CAGR 43% -6% 20% -4%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 4% 3% 12% 6%
ROE Average 5% 5% 5% 7%
ROCE Average 7% 7% 6% 9%

Jocil Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 136 142 148 159 168 172 174 181 196 204 206
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 12 11 10 10 9 8 7 8 5 4 4
Total Current Liabilities 101 90 41 86 123 82 36 59 62 63 47
Total Liabilities 249 243 200 254 300 262 217 247 263 270 257
Fixed Assets 82 74 67 63 59 54 50 48 48 47 44
Other Non-Current Assets 5 4 9 6 9 10 12 8 15 15 7
Total Current Assets 163 165 124 185 232 198 155 190 199 208 206
Total Assets 249 243 200 254 300 262 217 247 263 270 257

Jocil Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 2 6 7 7 3 13 16 16 22 6 2
Cash Flow from Operating Activities 14 32 11 11 -8 39 -4 9 14 -17 38
Cash Flow from Investing Activities -8 0 -5 0 -0 -9 5 -1 -20 14 -29
Cash Flow from Financing Activities -3 -31 -7 -14 18 -26 -2 -2 -10 -1 -6
Net Cash Inflow / Outflow 3 2 -0 -2 10 4 -0 6 -16 -4 3
Closing Cash & Cash Equivalent 6 7 7 4 13 16 16 22 6 2 5

Jocil Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 16.46 12.75 14.76 20.37 9.24 4.62 3.57 14.07 15.32 8.02 11.25
CEPS(Rs) 27.74 24.31 22.27 29.43 17.2 11.98 10.02 20.73 21.64 15.71 18.25
DPS(Rs) 6 5 6 7 3 2 1 3 3 2 2.5
Book NAV/Share(Rs) 152.97 159.87 166.94 178.62 189.38 193.76 195.58 203.26 220.82 229.3 232.4
Core EBITDA Margin(%) 7.69 6.28 6.81 7.32 3.78 3.09 1.67 4.25 3.65 2.05 1.93
EBIT Margin(%) 5.86 4.29 5.64 6.62 2.9 1.83 0.66 4.18 2.89 1.29 1.51
Pre Tax Margin(%) 5 3.88 5.35 6.34 2.48 1.42 0.31 3.95 2.73 1.27 1.39
PAT Margin (%) 3.18 2.7 3.56 4.2 2 1.18 0.79 2.8 2.41 0.95 1.09
Cash Profit Margin (%) 5.36 5.14 5.38 6.07 3.71 3.05 2.21 4.13 3.4 1.85 1.76
ROA(%) 6.18 4.6 5.92 7.97 2.96 1.46 1.32 5.39 5.34 2.68 3.79
ROE(%) 11.1 8.15 9.03 11.79 5.02 2.41 1.84 7.05 7.23 3.57 4.88
ROCE(%) 16.34 11.08 13.25 17.45 6.54 3.39 1.48 10.07 8.43 4.8 6.67
Receivable days 41.93 43.49 45.83 46.25 67.57 73.42 48.37 56.58 53.66 38.59 29.16
Inventory Days 42.86 51.14 57.58 46.49 48.46 57.95 51.05 53.05 48.51 44.84 37.86
Payable days 11.54 20.94 24.23 17.37 31.56 33.49 15.83 26.01 28.37 19.72 14.26
PER(x) 5.35 7.06 7.04 8.05 17.65 32.85 31.03 6.58 9.38 24.08 13.46
Price/Book(x) 0.58 0.56 0.62 0.92 0.86 0.78 0.57 0.46 0.65 0.84 0.65
Dividend Yield(%) 6.82 5.55 5.77 4.27 1.84 1.32 0.9 3.24 2.09 1.04 1.65
EV/Net Sales(x) 0.27 0.23 0.29 0.38 0.42 0.36 0.22 0.15 0.21 0.23 0.14
EV/Core EBITDA(x) 2.93 2.99 3.5 4.1 8.37 9.57 10.62 2.69 5.53 10.4 6.45
Net Sales Growth(%) 4.13 -7.98 -11.89 18.88 -4.36 -9.13 17.85 10.89 26.69 33.29 21.99
EBIT Growth(%) 21.38 -32.98 14.96 37.38 -58.18 -46.55 -58.08 599.49 -12.61 -40.24 42.32
PAT Growth(%) 16.93 -22.54 15.73 38.06 -54.64 -49.99 -22.66 293.51 8.95 -47.63 40.25
EPS Growth(%) 16.93 -22.54 15.73 38.06 -54.64 -49.99 -22.66 293.51 8.95 -47.63 40.25
Debt/Equity(x) 0.26 0.09 0.07 0.06 0.17 0.04 0.05 0.05 0.01 0.02 0.01
Current Ratio(x) 1.61 1.83 3.01 2.15 1.89 2.42 4.32 3.23 3.22 3.32 4.37
Quick Ratio(x) 1.05 1.16 1.66 1.53 1.44 1.74 2.73 1.99 1.97 1.6 2.61
Interest Cover(x) 6.78 10.42 19.64 23.95 6.89 4.49 1.89 18.23 18.36 56.3 12.22
Total Debt/Mcap(x) 0.46 0.15 0.11 0.06 0.2 0.05 0.08 0.1 0.02 0.03 0.01

Jocil Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 55.02 55.02 55.02 55.02 55.02 55.02 55.02 55.02 55.02 55.02
FII 0 0 0 0.03 0 0 0 0.03 0.29 0.01
DII 0 0 0 0 0 0 0 0 0 0
Public 44.98 44.98 44.98 44.95 44.98 44.98 44.98 44.95 44.69 44.97
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at 0.8 times its book value
  • Debtor days have improved from 19.72 to 14.26days.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 5% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Jocil News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....